派格生物医药-B(02565)今日盘中大幅上涨，涨幅一度达到18.91%，表现异常强劲。
消息面上，此次股价异动与公司近期公布的一则消息密切相关。派格生物医药宣布，其基石投资者已同意自愿延长禁售期，在原定期满日（4月30日）后，直至5月20日期间不会以任何方式减持所持股份。公司方面认为，此举体现了基石投资者对公司未来前景的坚定信心，这种信心源于公司在技术研发方面的持续推进能力以及在重大临床里程碑上取得的显著进展。
分析指出，派格生物医药是国内少数能够实现药用聚乙二醇原料自主生产，并将其整合应用于慢性疾病药物全流程开发的企业。公司通过定向研发具有“新靶标、新作用位点、新作用机制”的创新分子实体，构建了机制互补、兼具临床价值与商业潜力的多元化产品管线，这为其长期发展奠定了坚实基础。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.